Morgan Stanley’s Aquestive Therapeutics AQST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.68M Sell
1,414,061
-113,228
-7% -$375K ﹤0.01% 4106
2025
Q1
$4.43M Buy
1,527,289
+790,400
+107% +$2.29M ﹤0.01% 4026
2024
Q4
$2.62M Buy
736,889
+65,400
+10% +$233K ﹤0.01% 4512
2024
Q3
$3.34M Buy
671,489
+115,503
+21% +$575K ﹤0.01% 4272
2024
Q2
$1.45M Buy
555,986
+463,064
+498% +$1.2M ﹤0.01% 4764
2024
Q1
$396K Buy
92,922
+44,592
+92% +$190K ﹤0.01% 5416
2023
Q4
$97.6K Buy
48,330
+32,393
+203% +$65.4K ﹤0.01% 6173
2023
Q3
$24.4K Sell
15,937
-5,932
-27% -$9.08K ﹤0.01% 6427
2023
Q2
$36.1K Buy
21,869
+17,199
+368% +$28.4K ﹤0.01% 6342
2023
Q1
$5.32K Sell
4,670
-1,002
-18% -$1.14K ﹤0.01% 7036
2022
Q4
$5.12K Sell
5,672
-27,709
-83% -$25K ﹤0.01% 7140
2022
Q3
$39K Buy
33,381
+13,517
+68% +$15.8K ﹤0.01% 6514
2022
Q2
$13K Sell
19,864
-76,269
-79% -$49.9K ﹤0.01% 7129
2022
Q1
$250K Sell
96,133
-99,389
-51% -$258K ﹤0.01% 5790
2021
Q4
$760K Sell
195,522
-50,626
-21% -$197K ﹤0.01% 5271
2021
Q3
$1.07M Sell
246,148
-307,579
-56% -$1.34M ﹤0.01% 5005
2021
Q2
$2.2M Buy
553,727
+195,685
+55% +$777K ﹤0.01% 4553
2021
Q1
$1.86M Buy
358,042
+323,269
+930% +$1.68M ﹤0.01% 4303
2020
Q4
$186K Sell
34,773
-608,110
-95% -$3.25M ﹤0.01% 5628
2020
Q3
$3.12M Buy
642,883
+586,243
+1,035% +$2.85M ﹤0.01% 3211
2020
Q2
$275K Buy
56,640
+36,926
+187% +$179K ﹤0.01% 4916
2020
Q1
$43K Sell
19,714
-303
-2% -$661 ﹤0.01% 5521
2019
Q4
$116K Buy
20,017
+15,987
+397% +$92.6K ﹤0.01% 5607
2019
Q3
$13K Sell
4,030
-13,293
-77% -$42.9K ﹤0.01% 6124
2019
Q2
$73K Buy
17,323
+15,174
+706% +$63.9K ﹤0.01% 5455
2019
Q1
$15K Sell
2,149
-5,871
-73% -$41K ﹤0.01% 6090
2018
Q4
$51K Sell
8,020
-261
-3% -$1.66K ﹤0.01% 5755
2018
Q3
$145K Buy
+8,281
New +$145K ﹤0.01% 5576